Uterine Fibroids
|
group |
Neoplasms
|
Neoplastic Process
|
569
|
154
|
0.500 |
None |
0.978 |
46 |
|
1996 |
2020 |
Russell-Silver syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
104
|
12
|
0.440 |
strong |
0.750 |
4 |
2
|
2010 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.400 |
None |
0.949 |
156 |
|
1996 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.400 |
None |
0.981 |
54 |
|
1998 |
2020 |
Benign Neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
371
|
7
|
0.400 |
None |
1.000 |
15 |
|
1997 |
2019 |
Liposarcoma, well differentiated
|
disease |
Neoplasms
|
Neoplastic Process
|
54
|
|
0.400 |
None |
1.000 |
10 |
|
1997 |
2015 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.400 |
None |
1.000 |
3 |
3
|
2013 |
2019 |
Liposarcoma, Dedifferentiated
|
disease |
Neoplasms
|
Neoplastic Process
|
95
|
|
0.350 |
None |
1.000 |
5 |
|
2008 |
2019 |
Salivary Gland Pleomorphic Adenoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
63
|
9
|
0.340 |
None |
1.000 |
6 |
|
1997 |
2018 |
12q14 microdeletion syndrome
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases; Endocrine System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
2
|
|
0.340 |
None |
1.000 |
5 |
|
2009 |
2017 |
Myolipoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.330 |
None |
1.000 |
4 |
|
2000 |
2017 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
32
|
8
|
0.300 |
strong |
1.000 |
1 |
|
2018 |
2018 |
Radiolabeled somatostatin analog study
|
phenotype |
|
Diagnostic Procedure
|
3
|
|
0.300 |
strong |
1.000 |
1 |
|
2018 |
2018 |
Dwarfism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases
|
Congenital Abnormality
|
1261
|
77
|
0.170 |
None |
1.000 |
7 |
|
2009 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.130 |
None |
0.833 |
6 |
4
|
2012 |
2019 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.120 |
None |
1.000 |
3 |
1
|
2012 |
2019 |
Failure to Thrive
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
842
|
10
|
0.120 |
None |
1.000 |
2 |
|
2009 |
2009 |
Fetal Growth Retardation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
1037
|
21
|
0.110 |
None |
1.000 |
1 |
|
2018 |
2018 |
Osteopoikilosis (disorder)
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
7
|
3
|
0.110 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
53 |
|
1996 |
2020 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
50 |
|
2005 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.957 |
47 |
|
1995 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.970 |
33 |
|
1998 |
2020 |
Lipoma
|
disease |
Neoplasms
|
Neoplastic Process
|
87
|
9
|
0.100 |
None |
1.000 |
31 |
|
1996 |
2017 |